Canaccord raised the firm’s price target on Alnylam (ALNY) to $429 from $415 and keeps a Buy rating on the shares. The firm updated its model following Q4 results which was largely uneventful following its January preannouncement of a slight top and bottom line miss. But the bigger picture is that the Amvuttra launch in TTR is going really well and longer term they continue to see upside versus. the company’s and Street’s estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY:
- Alnylam price target raised to $429 from $415 at Canaccord
- Alnylam price target lowered to $249 from $415 at Canaccord
- Alnylam upgraded to Buy from Hold at Freedom Capital
- 3 ‘Strong Buy’ Stocks to Buy Now, 2/13/2026, According to Top Analysts
- Alnylam price target lowered to $360 from $408 at Morgan Stanley
